Yajun Yun

Biographic Data

ID7960757
NAMEYajun Yun
GIVEN NAMESYajun
FAMILY NAMEYun
SIGNATUREYUN Y
AFFILIATIONSBeijing HuiLongGuan Hospital
VERIFIEDNo
TOTAL WORKS6
TOTAL CITATIONS0
AUTHOR COUNT6
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Association between homocysteine levels and cognition in late-life depression

    Open AccessNing Fan, Qi Zhang et al.ARTICLEFrontiers in Psychiatry2025

    Patients with LLD often exhibit cognitive impairment and elevated Hcy levels. Notably, the association between Hcy and cognitive function is influenced by the patients' baseline cognitive status. This study offers novel insights into the mechanisms underlying cognitive impairment in patients with depression

  • A network analysis of facial and vocal emotion recognition deficits in schizophrenia

    Open AccessWenxuan Zhao, Qi Zhang et al.ARTICLEFrontiers in Psychiatry2025

    These findings underscore the importance of emotion recognition impairments in schizophrenia and their strong association with cognitive deficits. Future interventions should focus on targeted cognitive and affective training strategies. Incorporating multimodal assessments into clinical evaluations may enhance diagnostic accuracy

  • Homocysteine levels in first-episode patients with psychiatric disorders

    Open AccessNing Fan, Wenxuan Zhao et al.ARTICLEFrontiers in Psychiatry2024

    A high homocysteine (Hcy) level is a risk factor for schizophrenia, depression, and bipolar disorder. However, the role of hyperhomocysteinemia as either an independent factor or an auxiliary contributor to specific psychiatric symptoms or disorders remains unclear. This study aimed to examine Hcy levels in first-episode inpatients with psychotic symptoms and various psychiatric diseases to elucidate the association between Hcy levels and psychia…

  • Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia

    Open AccessHuimei An, Hongzhen Fan et al.ARTICLEFrontiers in Psychiatry2022

    These results demonstrate that OLA and its metabolite DMO may have different effects on OLA-induced metabolic abnormalities. DMO might have a counteracting effects on glucose-insulin homeostasis and lipid metabolic abnormalities, which suggests that regular measure of various metabolic parameters and drug monitoring on both OLA and DMO are recommended in OLA-treated patients with schizophrenia

  • High-Dose Betahistine Improves Cognitive Function in Patients With Schizophrenia

    Open AccessYongqian Wang, Xu-Feng Huang et al.ARTICLEFrontiers in Psychiatry2021

    Background: There is currently no effective treatment for cognitive impairment associated with schizophrenia (CIAS). Recent studies have shown that increased histamine levels in the brain may help to improve CIAS symptoms. Betahistine is an H1-receptor agonist and H3-receptor antagonist. This study evaluated the effect of high-dose betahistine on cognitive function as well as its safety in Chinese Han patients with schizophrenia. Methods: This ra…

  • Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality

    Open AccessQi Zhang, Yajun Yun et al.ARTICLEFrontiers in Psychiatry2021

    The microbiota-gut-brain axis plays a critical role in the pathogenesis of major depressive disorder (MDD) and related subclinical symptoms. However, studies on the gut microbiota in MDD are inconsistent, and data on MDD's effects on sleep are lacking. This study aimed to analyze the gut microbiota composition and sleep quality of patients with MDD. We performed 16S rRNA sequencing of stool samples from 36 patients with MDD and 45 healthy control…